{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T21:03:46Z","timestamp":1789506226131,"version":"build-2803163510"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T00:00:00Z","timestamp":1756252800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T00:00:00Z","timestamp":1756252800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Vanke Special Fund for Public Health and Health Discipline Development, Tsinghua University","award":["2022Z82WKJ008"],"award-info":[{"award-number":["2022Z82WKJ008"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82430087"],"award-info":[{"award-number":["82430087"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Human umbilical cord mesenchymal stem cells (HUMSCs) are effective therapies for inflammatory bowel disease. However, the mechanisms remain unresolved. We found HUMSCs express CD126 (IL-6 receptor), which indicated CD126 sub-populations might show a distinct response to inflammation. In the present study, we explored whether CD126 is a critical molecule for HUMSCs in regulating inflammation.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>We assessed the regulatory effects of CD126 high (CD126<jats:sup>hi<\/jats:sup>) on the T lymphocyte subpopulations and related cytokines in the dextran sulfate sodium (DSS)-induced colitis model. The effect of CD126<jats:sup>hi<\/jats:sup> was evaluated by Hematoxylin and Eosin (H&amp;E) staining, fluorescence-activated cell sorting (FACS), and enzyme-linked immunosorbent assay (ELISA) analyses. Statistical significance was typically determined using Student\u2019s t-test or one-way analysis of variance (ANOVA) with Tukey test.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>The disease symptoms were markedly ameliorated and the interleukin-6 (IL-6), interleukin-17 (IL-17), interferon-\u03b3 (IFN-\u03b3), Tumor necrosis factor-\u03b1 (TNF-\u03b1), and interleukin-4 (IL-4) levels were significantly reduced in DSS-treated mice administered with CD126<jats:sup>hi<\/jats:sup> HUMSCs but not in DSS-treated mice administered with CD126 low (CD126<jats:sup>lo<\/jats:sup>) HUMSCs. Intriguingly, CD126<jats:sup>hi<\/jats:sup> HUMSCs significantly increased the levels of transforming growth factor-\u03b2 (TGF-\u03b21) and interleukin-10 (IL-10) in DSS-treated mice, accompanied by an increase in regulatory T cells (Treg cells). In vitro experiments showed that CD126<jats:sup>hi<\/jats:sup> HUMSCs secreted TGF-\u03b21 in response to IL-6 stimulation, while CD126<jats:sup>lo<\/jats:sup> HUMSCs were latent in the inflammatory environment. We considered that TGF-\u03b21 secreted by CD126<jats:sup>hi<\/jats:sup> HUMSCs regulated the balance of Treg cells and thus promoted the recovery of murine colitis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>Our results revealed a mechanism wherein CD126<jats:sup>hi<\/jats:sup> HUMSCs function as inflammatory sensors and secrete anti-inflammatory cytokines to rebalance the population of T cells. This study shed light on the potential therapeutic application of CD126<jats:sup>hi<\/jats:sup> HUMSCs for inflammatory diseases such as inflammatory bowel disease.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s13023-025-03993-w","type":"journal-article","created":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T08:35:01Z","timestamp":1756283701000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["CD126hi umbilical cord mesenchymal stem cells sensitive to IL-6 ameliorate inflammatory bowel disease by producing TGF-\u03b21"],"prefix":"10.1186","volume":"20","author":[{"given":"Yanxia","family":"Fu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingchen","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinyin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianqiu","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhijie","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojue","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongliang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0519-8920","authenticated-orcid":false,"given":"Junfeng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,27]]},"reference":[{"key":"3993_CR1","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/nprot.2007.41","volume":"2","author":"S Wirtz","year":"2007","unstructured":"Wirtz S, Neufert C, Weigmann B, et al. Chemically induced mouse models of intestinal inflammation. Nat Protoc. 2007;2:541\u20136.","journal-title":"Nat Protoc"},{"key":"3993_CR2","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1056\/NEJMoa033402","volume":"351","author":"PJ Mannon","year":"2004","unstructured":"Mannon PJ, Fuss IJ, Mayer L, et al. Anti-interleukin-12 antibody for active crohn\u2019s disease. N Engl J Med. 2004;351:2069\u201379.","journal-title":"N Engl J Med"},{"key":"3993_CR3","doi-asserted-by":"publisher","first-page":"122189","DOI":"10.1016\/j.lfs.2023.122189","volume":"334","author":"Y Fu","year":"2023","unstructured":"Fu Y, Zhang C, Xie H, Wu Z, Tao Y, Wang Z, Gu M, Wei P, Lin S, Li R, He Y, Sheng J, Xu J, Wang J, Pan Y. Human umbilical cord mesenchymal stem cells alleviated TNBS-induced colitis in mice by restoring the balance of intestinal microbes and immunoregulation. Life Sci. 2023;334:122189.","journal-title":"Life Sci"},{"key":"3993_CR4","doi-asserted-by":"publisher","first-page":"18228","DOI":"10.3748\/wjg.v20.i48.18228","volume":"20","author":"C Goncalves Fda","year":"2014","unstructured":"Goncalves Fda C, Schneider N, Pinto FO, et al. Intravenous vs intraperitoneal mesenchymal stem cells administration: what is the best route for treating experimental colitis? World J Gastroenterol. 2014;20:18228\u201339.","journal-title":"World J Gastroenterol"},{"key":"3993_CR5","doi-asserted-by":"publisher","first-page":"1617229","DOI":"10.1155\/2022\/1617229","volume":"2022","author":"Y Fu","year":"2022","unstructured":"Fu Y, Li J, Li M, Xu J, Rong Z, Ren F, Wang Y, Sheng J, Chang Z. Umbilical cord mesenchymal stem cells ameliorate Inflammation-Related tumorigenesis via modulating macrophages. Stem Cells Int. 2022;2022:1617229.","journal-title":"Stem Cells Int"},{"key":"3993_CR6","doi-asserted-by":"publisher","first-page":"121206","DOI":"10.1016\/j.lfs.2022.121206","volume":"312","author":"K Abdolmohammadi","year":"2023","unstructured":"Abdolmohammadi K, Mahmoudi T, Alimohammadi M, Tahmasebi S, Zavvar M, Hashemi SM. Mesenchymal stem cell-based therapy as a new therapeutic approach for acute inflammation. Life Sci. 2023;312:121206.","journal-title":"Life Sci"},{"issue":"5","key":"3993_CR7","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.3390\/cells9051157","volume":"9","author":"DH Ha","year":"2020","unstructured":"Ha DH, Kim HK, Lee J, Kwon HH, Park GH, Yang SH, Jung JY, Choi H, Lee JH, Sung S, Yi YW, Cho BS. Mesenchymal stem\/stromal Cell-Derived exosomes for Immunomodulatory therapeutics and skin regeneration. Cells. 2020;9(5):1157.","journal-title":"Cells"},{"issue":"20","key":"3993_CR8","doi-asserted-by":"publisher","first-page":"2668","DOI":"10.1002\/1873-3468.14460","volume":"596","author":"Y Fu","year":"2022","unstructured":"Fu Y, Li J, Zhang Z, Ren F, Wang Y, Jia H, Liu J, Chang Z. Umbilical cord mesenchymal stem cell-derived exosomes alleviate collagen-induced arthritis by balancing the population of Th17 and regulatory T cells. FEBS Lett. 2022;596(20):2668\u201377.","journal-title":"FEBS Lett"},{"issue":"1","key":"3993_CR9","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1186\/s13287-024-03834-w","volume":"15","author":"C Li","year":"2024","unstructured":"Li C, Wu F, Mao J, Wang Y, Zhu J, Hong K, Xie H, Zhou X, Tian J, Wen C. Mesenchymal stem cells-derived extracellular vesicles ameliorate lupus nephritis by regulating T and B cell responses. Stem Cell Res Ther. 2024;15(1):216.","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"3993_CR10","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1186\/s13287-023-03543-w","volume":"14","author":"H Yang","year":"2023","unstructured":"Yang H, Cheong S, He Y, Lu F. Mesenchymal stem cell-based therapy for autoimmune-related fibrotic skin diseases-systemic sclerosis and sclerodermatous graft-versus-host disease. Stem Cell Res Ther. 2023;14(1):372.","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"3993_CR11","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.arcmed.2020.08.006","volume":"52","author":"DE Rodr\u00edguez-Fuentes","year":"2021","unstructured":"Rodr\u00edguez-Fuentes DE, Fern\u00e1ndez-Garza LE, Samia-Meza JA, Barrera-Barrera SA, Caplan AI, Barrera-Salda\u00f1a HA. Mesenchymal stem cells current clinical applications: A systematic review. Arch Med Res. 2021;52(1):93\u2013101.","journal-title":"Arch Med Res"},{"issue":"8","key":"3993_CR12","doi-asserted-by":"publisher","first-page":"2781","DOI":"10.1007\/s12015-022-10397-x","volume":"18","author":"M Mahmoudi","year":"2022","unstructured":"Mahmoudi M, Hoseinzadeh A, Rezaieyazdi Z, Afshari JT, Mahmoudi A, Heydari S. Cross talk between mesenchymal stem\/stromal cells and innate immunocytes concerning lupus disease. Stem Cell Rev Rep. 2022;18(8):2781\u201396.","journal-title":"Stem Cell Rev Rep"},{"issue":"7","key":"3993_CR13","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1038\/s41419-018-0801-9","volume":"9","author":"Y Yin","year":"2018","unstructured":"Yin Y, Hao H, Cheng Y, Zang L, Liu J, Gao J, Xue J, Xie Z, Zhang Q, Han W, Mu Y. Human umbilical cord-derived mesenchymal stem cells direct macrophage polarization to alleviate pancreatic Islets dysfunction in type 2 diabetic mice. Cell Death Dis. 2018;9(7):760.","journal-title":"Cell Death Dis"},{"issue":"11","key":"3993_CR14","doi-asserted-by":"publisher","first-page":"5924","DOI":"10.3390\/ijms23115924","volume":"23","author":"BR Gauthier","year":"2022","unstructured":"Gauthier BR, Rubio-Contreras D, G\u00f3mez-Rosado JC, Capit\u00e1n-Morales LC, Hmadcha A, Soria B, Lachaud CC. Human omental mesothelial cells impart an Immunomodulatory landscape impeding B- and T-Cell activation. Int J Mol Sci. 2022;23(11):5924.","journal-title":"Int J Mol Sci"},{"key":"3993_CR15","doi-asserted-by":"publisher","first-page":"1024509","DOI":"10.3389\/fimmu.2022.1024509","volume":"13","author":"W Cen","year":"2023","unstructured":"Cen W, Umrath F, Salgado AJ, Reinert S, Alexander D. Secretomes derived from osteogenically differentiated jaw periosteal cells inhibit phenotypic and functional maturation of CD14+ monocyte-derived dendritic cells. Front Immunol. 2023;13:1024509.","journal-title":"Front Immunol"},{"key":"3993_CR16","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.stem.2012.05.015","volume":"10","author":"A Keating","year":"2012","unstructured":"Keating A. Mesenchymal stromal cells: new directions. Cell Stem Cell. 2012;10:709\u201316.","journal-title":"Cell Stem Cell"},{"issue":"8","key":"3993_CR17","doi-asserted-by":"publisher","first-page":"9404","DOI":"10.1096\/fj.201900047R","volume":"33","author":"N Murphy","year":"2019","unstructured":"Murphy N, Treacy O, Lynch K, Morcos M, Lohan P, Howard L, Fahy G, Griffin MD, Ryan AE, Ritter T. TNF-\u03b1\/IL-1\u03b2-licensed mesenchymal stromal cells promote corneal allograft survival via myeloid cell-mediated induction of Foxp3+ regulatory T cells in the lung. FASEB J. 2019;33(8):9404\u201321.","journal-title":"FASEB J"},{"key":"3993_CR18","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s13287-015-0055-8","volume":"6","author":"RJ Tang","year":"2015","unstructured":"Tang RJ, Shen SN, Zhao XY, et al. Mesenchymal stem cells-regulated Treg cells suppress colitis-associated colorectal cancer. Stem Cell Res Ther. 2015;6:71.","journal-title":"Stem Cell Res Ther"},{"key":"3993_CR19","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1126\/science.284.5411.143","volume":"284","author":"F Mark","year":"1999","unstructured":"Mark F, Pittenger AMM, Stephen C, Beck,Rama K, Jaiswal,Robin Douglas,Joseph D, Mosca,Mark A, Moorman,Donald W. Simonetti,Stewart craig,daniel R. Marshak. Multilineage potential of adult human mesenchymal stem cells. Science. 1999;284:143\u20137.","journal-title":"Science"},{"key":"3993_CR20","doi-asserted-by":"publisher","first-page":"31881","DOI":"10.1038\/srep31881","volume":"6","author":"Y Wang","year":"2016","unstructured":"Wang Y, Jiang X, Zhu J, et al. IL-21\/IL-21R signaling suppresses intestinal inflammation induced by DSS through regulation of Th responses in lamina propria in mice. Sci Rep. 2016;6:31881.","journal-title":"Sci Rep"},{"key":"3993_CR21","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/978-1-62703-604-7_7","volume":"1066","author":"JC Ibla","year":"2013","unstructured":"Ibla JC, Khoury J. Methods to assess tissue permeability. Methods Mol Biol. 2013;1066:81\u20138.","journal-title":"Methods Mol Biol"},{"issue":"26","key":"3993_CR22","doi-asserted-by":"publisher","first-page":"12204","DOI":"10.7150\/thno.47683","volume":"10","author":"J Xu","year":"2020","unstructured":"Xu J, Wang X, Chen J, Chen S, Li Z, Liu H, Bai Y, Zhi F. Embryonic stem cell-derived mesenchymal stem cells promote colon epithelial integrity and regeneration by elevating Circulating IGF-1 in colitis mice. Theranostics. 2020;10(26):12204\u201322.","journal-title":"Theranostics"},{"key":"3993_CR23","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.stem.2014.01.013","volume":"14","author":"M Mendicino","year":"2014","unstructured":"Mendicino M, Bailey AM, Wonnacott K, et al. MSC-based product characterization for clinical trials: an FDA perspective. Cell Stem Cell. 2014;14:141\u20135.","journal-title":"Cell Stem Cell"},{"key":"3993_CR24","doi-asserted-by":"crossref","unstructured":"Yang ZXHZ-B, Ji YR, Wang YW, Liang L et al. CD106 identifies a subpopulat ion of mesench Ymal stem cells with unique Immu nomodulato Ry properties. PLoS ONE 2013;8.","DOI":"10.1371\/journal.pone.0059354"},{"issue":"15","key":"3993_CR25","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.3390\/cells11152263","volume":"11","author":"JP Bikorimana","year":"2022","unstructured":"Bikorimana JP, Saad W, Abusarah J, Lahrichi M, Talbot S, Shammaa R, Rafei M. CD146 defines a mesenchymal stromal cell subpopulation with enhanced suppressive properties. Cells. 2022;11(15):2263.","journal-title":"Cells"},{"key":"3993_CR26","first-page":"100031","volume":"5","author":"B Brinkhof","year":"2020","unstructured":"Brinkhof B, Zhang B, Cui Z, Ye H, Wang H. ALCAM (CD166) as a gene expression marker for human mesenchymal stromal cell characterisation. Gene X. 2020;5:100031.","journal-title":"Gene X"},{"key":"3993_CR27","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1002\/eji.201142327","volume":"42","author":"D Bernardo","year":"2012","unstructured":"Bernardo D, Vallejo-Diez S, Mann ER, et al. IL-6 promotes immune responses in human ulcerative colitis and induces a skin-homing phenotype in the dendritic cells and Tcells they stimulate. Eur J Immunol. 2012;42:1337\u201353.","journal-title":"Eur J Immunol"},{"issue":"5","key":"3993_CR28","doi-asserted-by":"publisher","first-page":"2262","DOI":"10.3390\/ijerph18052262","volume":"18","author":"S Riemschneider","year":"2021","unstructured":"Riemschneider S, Hoffmann M, Slanina U, Weber K, Hauschildt S, Lehmann J. Indol-3-Carbinol and Quercetin ameliorate chronic DSS-Induced colitis in C57BL\/6 mice by AhR-Mediated Anti-Inflammatory mechanisms. Int J Environ Res Public Health. 2021;18(5):2262.","journal-title":"Int J Environ Res Public Health"},{"issue":"4","key":"3993_CR29","doi-asserted-by":"publisher","first-page":"3817","DOI":"10.3390\/ijms24043817","volume":"24","author":"Y Haneishi","year":"2023","unstructured":"Haneishi Y, Furuya Y, Hasegawa M, Picarelli A, Rossi M, Miyamoto J. Inflammatory bowel diseases and gut microbiota. Int J Mol Sci. 2023;24(4):3817.","journal-title":"Int J Mol Sci"},{"key":"3993_CR30","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.autrev.2013.06.004","volume":"13","author":"A Geremia","year":"2014","unstructured":"Geremia A, Biancheri P, Allan P, et al. Innate and adaptive immunity in inflammatory bowel disease. Autoimmun Rev. 2014;13:3\u201310.","journal-title":"Autoimmun Rev"},{"issue":"11","key":"3993_CR31","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.3390\/cells11111851","volume":"11","author":"C Huang","year":"2022","unstructured":"Huang C, Mei Q, Lou L, Huang Z, Fu Y, Fan J, Wang J, Yin N, Zheng Y, Lu Y, Zeng Y. Ulcerative colitis in response to fecal microbiota transplantation via modulation of gut microbiota and Th17\/Treg cell balance. Cells. 2022;11(11):1851.","journal-title":"Cells"},{"issue":"3","key":"3993_CR32","doi-asserted-by":"publisher","first-page":"2696","DOI":"10.3390\/ijms24032696","volume":"24","author":"R Gomez-Bris","year":"2023","unstructured":"Gomez-Bris R, Saez A, Herrero-Fernandez B, Rius C, Sanchez-Martinez H, Gonzalez-Granado JM. CD4 T-Cell subsets and the pathophysiology of inflammatory bowel disease. Int J Mol Sci. 2023;24(3):2696.","journal-title":"Int J Mol Sci"},{"key":"3993_CR33","doi-asserted-by":"publisher","first-page":"923","DOI":"10.2217\/imt.13.87","volume":"5","author":"LP McLean","year":"2013","unstructured":"McLean LP, Cross RK, Shea-Donohue T. Combined Blockade of IL-17A and IL-17F May prevent the development of experimental colitis. Immunotherapy. 2013;5:923\u20135.","journal-title":"Immunotherapy"},{"issue":"6","key":"3993_CR34","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1111\/ajt.17001","volume":"22","author":"SK Mittal","year":"2022","unstructured":"Mittal SK, Cho W, Elbasiony E, Guan Y, Foulsham W, Chauhan SK. Mesenchymal stem cells augment regulatory T cell function via CD80-mediated interactions and promote allograft survival. Am J Transpl. 2022;22(6):1564\u201377.","journal-title":"Am J Transpl"},{"key":"3993_CR35","doi-asserted-by":"publisher","first-page":"1103617","DOI":"10.3389\/fimmu.2023.1103617","volume":"14","author":"M Zhang","year":"2023","unstructured":"Zhang M, Li X, Zhang Q, Yang J, Liu G. Roles of macrophages on ulcerative colitis and colitis-associated colorectal cancer. Front Immunol. 2023;14:1103617.","journal-title":"Front Immunol"},{"key":"3993_CR36","first-page":"1297","volume":"21","author":"D Lissner","year":"2015","unstructured":"Lissner D, Schumann M, Batra A, et al. Monocyte and M1 Macrophage-induced barrier defect contributes to chronic intestinal inflammation in IBD. Inflamm Bowel Dis. 2015;21:1297\u2013305.","journal-title":"Inflamm Bowel Dis"},{"key":"3993_CR37","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1172\/JCI59643","volume":"122","author":"A Sica","year":"2012","unstructured":"Sica A, Mantovani A. Macrophage plasticity and polarization: in vivo veritas. J Clin Invest. 2012;122:787\u201395.","journal-title":"J Clin Invest"},{"key":"3993_CR38","doi-asserted-by":"publisher","first-page":"173090","DOI":"10.1016\/j.ejphar.2020.173090","volume":"877","author":"C Yunna","year":"2020","unstructured":"Yunna C, Mengru H, Lei W, Weidong C. Macrophage M1\/M2 polarization. Eur J Pharmacol. 2020;877:173090.","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"3993_CR39","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1186\/s12876-023-03054-1","volume":"23","author":"S Ebihara","year":"2023","unstructured":"Ebihara S, Urashima T, Amano W, Yamamura H, Konishi N. Macrophage polarization toward M1 phenotype in T cell transfer colitis model. BMC Gastroenterol. 2023;23(1):411.","journal-title":"BMC Gastroenterol"},{"key":"3993_CR40","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.stem.2013.09.006","volume":"13","author":"ME Bernardo","year":"2013","unstructured":"Bernardo ME, Fibbe WE. Mesenchymal stromal cells: sensors and switchers of inflammation. Cell Stem Cell. 2013;13:392\u2013402.","journal-title":"Cell Stem Cell"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-03993-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-025-03993-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-03993-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T18:34:06Z","timestamp":1757442846000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-025-03993-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,27]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3993"],"URL":"https:\/\/doi.org\/10.1186\/s13023-025-03993-w","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,27]]},"assertion":[{"value":"4 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The IACUC (Institutional Animal Care and Use Committee) of Tsinghua University approved all animal experimental protocols used in this study (No. 2020-3-20).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"458"}}